4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells.

4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells.
复制标题

DOI:
10.1007/s00280-005-0016-5
复制
发表时间:
2006-01-01
影响因子:
3
通讯作者:
Sasaki, Mutsuo
Sasaki, Mutsuo
中科院分区:
医学3区
文献类型:
--
作者:
Nakazawa, Hideaki;Yoshihara, Shuichi;Sasaki, Mutsuo

文献摘要

被引文献

相似文献

透明质酸(HA)是一种普遍存在的细胞外基质的主要成分,是各种生理过程所必需的。它在生物屏障中扮演着非常重要的角色。我们先前报道了4-甲基伞形酮(MU)抑制培养的人皮肤成纤维细胞、马链球菌FM100和B16F10黑色素瘤细胞的HA合成和细胞周围HA基质的形成。我们推测,MU介导的抑制HA合成和细胞外HA基质形成将增加抗癌药物的疗效。我们已经在体外用夹心结合蛋白实验和颗粒排斥实验证明,在人KP1-NL胰腺癌细胞中,MU分别抑制HA合成和细胞周围HA基质的形成。AlamarBlue实验显示,MU可增强吉西他滨对KP1-NL细胞的抗癌作用。在体内,MU和吉西他滨同时应用于患有严重联合免疫缺陷病(SCID)的荷瘤小鼠,比单独使用吉西他滨更能缩小原发和转移瘤的大小。这些数据有力地表明MU和吉西他滨联合应用对人胰腺癌细胞是有效的。MU可能具有作为化学增敏剂的潜力,可能为我们提供一种新的抗癌策略。
Hyaluronan (HA) is a ubiquitous, major component of the pericellular matrix and is necessary for various physiological processes. It plays a very important role in biological barriers. We previously reported that 4-methylumbelliferone (MU) inhibits HA synthesis and pericellular HA matrix formation in cultured human skin fibroblasts, Streptococcus equi FM100, and B16F10 melanoma cells. We hypothesized that MU-mediated inhibition of HA synthesis and pericellular HA matrix formation would increase the efficacy of anticancer drugs. We have already demonstrated in vitro, using a sandwich binding protein assay and a particle exclusion assay, that MU inhibits HA synthesis and formation of the pericellular HA matrix, respectively, in human KP1-NL pancreatic cancer cells. AlamarBlue assay revealed that the anticancer effect of gemcitabine in KP1-NL cells was increased by pretreatment with MU. In vivo simultaneous administration of MU and gemcitabine to tumor-bearing mice with severe combined immunodeficiency disease (SCID) decreased the size of the primary and metastatic tumors more than did gemcitabine alone. These data strongly suggest that a combination of MU and gemcitabine is effective against human pancreatic cancer cells. MU may have potential as a chemosensitizer and may provide us with a new anticancer strategy.